Meta-analysis favors SubQ infliximab biosimilar over vedolizumab in Crohn’s diseaseFebruary 24, 2022IBD & Intestinal Disorders
Two factors linked to higher risk of long COVID in IBDFebruary 22, 2022COVID-19 UpdatesIBD & Intestinal Disorders
Breakthrough COVID-19 milder in vaccinated patients with IBDFebruary 14, 2022COVID-19 UpdatesIBD & Intestinal Disorders
C. difficile: New vancomycin-resistant strains raise concernsFebruary 9, 2022IBD & Intestinal Disorders
Steroid-free remission doesn’t decrease risk of Crohn’s disease progressionJanuary 27, 2022IBD & Intestinal Disorders
Therapeutic drug monitoring with infliximab improves IBD disease controlJanuary 26, 2022IBD & Intestinal Disorders
